LCTX

$1.01+0.00%

Lineage Cell Therapeutics, Inc.

Market Cap

$255M

Live price × SEC shares (Aug 3, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.62

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

19.5

TTM to Jun 2026 · revenue

P/B

4.2

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	3,681	6,608	1,725	1,069	13,083
Research & development	3,271	8,238	4,234	4,774	20,517
Operating income	(3,786)	(6,548)	(7,593)	(8,923)	(26,850)
Net income	(29,781)	851	(4,812)	1,482	(32,260)
EPS (basic) ($)	(0.13)		(0.02)	0.01	(0.14)
EPS (diluted) ($)	(0.13)		(0.03)	(0.03)	(0.19)
Weighted avg. shares (basic)	228,853		245,029	249,499
Weighted avg. shares (diluted)	228,853		261,175	261,471

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

9 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 6, 2026 accepted 4:11 PM ET	2.02Earnings release	Document SEC ↗
Jun 12, 2026 accepted 4:32 PM ET	5.07Shareholder vote8.01Other events	Document SEC ↗
May 12, 2026 accepted 4:10 PM ET	2.02Earnings release	Document SEC ↗
Mar 11, 2026 accepted 9:00 AM ET	8.01Other events	Document SEC ↗
Mar 5, 2026 accepted 4:10 PM ET	2.02Earnings release	Document SEC ↗
Nov 28, 2025 accepted 4:05 PM ET	8.01Other events	Document SEC ↗
Nov 24, 2025 accepted 6:49 AM ET	8.01Other events	Document SEC ↗
Nov 12, 2025 accepted 9:25 AM ET	8.01Other events	Document SEC ↗
Nov 6, 2025 accepted 4:12 PM ET	2.02Earnings release	Document SEC ↗
Aug 26, 2025 accepted 9:14 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗